Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05555030 · ClinicalTrials.gov registry record · NA
COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation
A NA study, sponsored by New Day Diagnostics.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05555030 is a NA study that has completed, run by New Day Diagnostics. The registered enrollment target is 100 participants.
The verdict
NCT05555030, a NA study, has completed, sponsored by New Day Diagnostics.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
SARS-CoV-2 rapid antigen over the counter clinical performance evaluation.
Interventions
- DEVICE iCura COVID-19 Antigen Rapid Home Test
- DIAGNOSTIC_TEST RT-PCR Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-08-04 |
| Est. Completion | 2022-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05555030
The ClinicalTrials.gov registry entry for NCT05555030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New Day Diagnostics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iCura COVID-19 Antigen Rapid Home Test is the first listed.
NCT05555030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05555030 about?
NCT05555030 is a clinical study titled "COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation". SARS-CoV-2 rapid antigen over the counter clinical performance evaluation.
What is the current status of trial NCT05555030?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2022-08-04. Estimated completion is 2022-12-20.
What interventions are being tested in trial NCT05555030?
The interventions under investigation include: iCura COVID-19 Antigen Rapid Home Test (DEVICE), RT-PCR Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05555030?
This trial is sponsored by New Day Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.